Morcellation and risk of malignancy in presumed ovarian fibromas/fibrothecomas

Wouter Froyman; Chiara Landolfo; Frédéric Amant; Thierry Van den Bosch; Ignace Vergote; An Coosemans; Antonia Testa; Lil Valentin; Tom Bourne; Ben Van Calster; Dirk Timmerman

doi:10.1016/S1470-2045(16)00022-X

Morcellation and risk of malignancy in presumed ovarian fibromas/fibrothecomas

Wouter Froyman, Chiara Landolfo, Frédéric Amant, Thierry Van den Bosch, Ignace Vergote, An Coosemans, Antonia Testa, Lil Valentin, Tom Bourne, Ben Van Calster, Dirk Timmerman

Obstetric, Gynaecological and Prenatal Ultrasound Research

Research output: Contribution to journal › Debate/Note/Editorial › peer-review

Original language	English
Pages (from-to)	273-4
Number of pages	2
Journal	The Lancet Oncology
Volume	17
Issue number	3
DOIs	https://doi.org/10.1016/S1470-2045(16)00022-X
Publication status	Published - 2016 Mar

Subject classification (UKÄ)

Cancer and Oncology
Obstetrics, Gynecology and Reproductive Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S1470-2045(16)00022-X

Cite this

@article{7e224478988149d7a9072208f0ab2aaa,

title = "Morcellation and risk of malignancy in presumed ovarian fibromas/fibrothecomas",

author = "Wouter Froyman and Chiara Landolfo and Fr{\'e}d{\'e}ric Amant and {Van den Bosch}, Thierry and Ignace Vergote and An Coosemans and Antonia Testa and Lil Valentin and Tom Bourne and Calster, {Ben Van} and Dirk Timmerman",

year = "2016",

month = mar,

doi = "10.1016/S1470-2045(16)00022-X",

language = "English",

volume = "17",

pages = "273--4",

journal = "The Lancet Oncology",

issn = "1474-5488",

publisher = "Elsevier",

number = "3",

}

TY - JOUR

T1 - Morcellation and risk of malignancy in presumed ovarian fibromas/fibrothecomas

AU - Froyman, Wouter

AU - Landolfo, Chiara

AU - Amant, Frédéric

AU - Van den Bosch, Thierry

AU - Vergote, Ignace

AU - Coosemans, An

AU - Testa, Antonia

AU - Valentin, Lil

AU - Bourne, Tom

AU - Calster, Ben Van

AU - Timmerman, Dirk

PY - 2016/3

Y1 - 2016/3

U2 - 10.1016/S1470-2045(16)00022-X

DO - 10.1016/S1470-2045(16)00022-X

M3 - Debate/Note/Editorial

C2 - 26972853

SN - 1474-5488

VL - 17

SP - 273

EP - 274

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 3

ER -